2014 Immunochemistry & Immunobiology Gordon Research Conference & Gordon Research

2014年免疫化学

基本信息

批准号：
8717116
负责人：
Nancy Ryan Gray
金额：
$ 0.9万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-03-01 至 2014-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8717116
关键词：
Academia Adult African Age Area Attention Autoimmunity Basic Science Biological Cells Childhood Clinic Clinical Commit Communicable Diseases Communities Competence Data Development Developmental Biology Developmental Process Diagnostic Diet Disease Educational process of instructing Ensure Environment Ethnic Origin Evaluation Faculty Financial cost Functional disorder Funding Future Gender Goals Hematopoiesis Human Hypersensitivity Immune Immune system Immunity Immunization Immunobiology Immunochemistry Immunologic Deficiency Syndromes Immunology Industry Infection Inflammation Inflammatory International Investigation Investments Joints Knowledge Left Malignant Neoplasms Memory Metabolic Metabolism Methods Molecular Outcome Outcome Measure Participant Peer Group Phenotype Physiological Processes Process Public Health Regulation Relaxation Research Research Personnel Research Priority Residencies Role Scholarship Site Skin Structure Techniques Therapeutic Time Tissues Training Translations Transplantation United States National Institutes of Health Vaccination Vaccine Research Visual Woman Work aged base cancer therapy career clinically relevant clinically significant cytokine experience fundamental research handicapping condition immune function improved induced pluripotent stem cell innovation insight meetings microbial colonization next generation novel novel strategies novel therapeutics peer public health relevance reproductive response success symposium tissue repair tool

项目摘要

DESCRIPTION (provided by applicant): The 2014 Gordon Research Conference (GRC) in Immunochemistry and Immunobiology will assemble 31 invited speakers and 165 participants for four and a half days, to consider and discuss the most recently obtained data across the breadth of immunology but focused on nine topical themes of profound biological and clinical relevance. In particular, the 2014 GRC will consider growing evidence that immune cells and molecules make critical, hitherto unanticipated contributions to areas of fundamental pathophysiology, such as metabolic regulation, that extend well beyond responses to infection. Additionally, the 2014 GRC will coincide with a surging tide of efficacy of new classes of immuno-therapeutics in inflammation, allergy, and cancer, and with new successes in vaccine research. In these contexts, the 2014 GRC aims for nothing less than a community-wide re-assessment of basic research priorities, general scholarship, and translational potentials in immunology. These aims can be achieved by an intensive conference, drawing on the full spectrum of age, gender, and ethnicity; of large enough size to capture relevant expertise, but small enough to promote interaction and discourse: such is the hallmark of the GRC in Immunochemistry and Immunobiology, soon to enter its 48th year. To give the 2014 GRC every chance of achieving its goals, it will be preceded by the first immunology Gordon Research Seminar (GRS), a one and one half day meeting that aims to prepare 50 young researchers for participation in the GRC, in a collegial, peer-led environment. The GRS will not simply enhance the 2014 GRC, but specifically aims to provide an inspirational training experience for the next generation. The faculty for the 2014 GRC/GRS must reflect aspiration and opportunity for all participants. Thus, all invited speakers are acknowledged or emerging leaders in their fields, with proven capacity to communicate and motivate, and who collectively represent the whole community, including a specific inclusion of African researchers. Session-leads, of whom 75% will be women, will contextualize and promote discussion of each presentation. The conference site is equipped with state-of-the-art audio-visual facilities and offers communal dining and relaxation activities. But, it is also sufficiently remote to dissuade participants from leaving th site. The 2014 GRC will continue a tradition of excellence, so widely perceived that invitees, despite being among the busiest in their field, have promptly committed to attending for at least 3 days. The 2014 GRC will also be innovative. As well as being the first in immunology to offer a GRS, other refinements have been made in response to evaluation of preceding conferences. Indeed, the 2014 GRC/GRS will include proven and innovative outcomes analysis. The 2010 and 2012 meetings received NIH funding, and earned the highest possible rating from most of the 95% of participants who submitted evaluations. There are therefore good grounds to believe that investment in the 2014 GRC will be highly productive.

说明（由申请人提供）：2014 年戈登免疫化学和免疫生物学研究会议 (GRC) 将聚集 31 名受邀演讲者和 165 名参与者，为期四天半，考虑和讨论免疫学领域最新获得的数据，但重点关注九个具有深远生物学和临床相关性的主题。特别是，2014 年 GRC 将考虑越来越多的证据，表明免疫细胞和分子对基本病理生理学领域（例如代谢调节）做出了迄今为止意想不到的关键贡献，其范围远远超出了对感染的反应。此外，2014 年 GRC 恰逢新型免疫治疗药物在炎症、过敏和癌症领域的疗效激增，以及疫苗研究的新成功。在这些背景下，2014 年 GRC 的目标无非是对免疫学领域的基础研究重点、一般学术和转化潜力进行全社会范围的重新评估。这些目标可以通过一次密集的会议来实现，充分利用年龄、性别和种族的各个方面；规模足够大，可以吸收相关专业知识，但又足够小，可以促进互动和讨论：这就是免疫化学和免疫生物学 GRC 的标志，即将进入其第 48 个年头。为了让 2014 年 GRC 有机会实现其目标，在其召开之前将举办首届免疫学戈登研究研讨会 (GRS)，这是一个为期一天半的会议，旨在为 50 名年轻研究人员参加 GRC 做好准备，以合议形式举行。，同行主导的环境。 GRS 不会简单地增强 2014 年 GRC，而是旨在为下一代提供鼓舞人心的培训体验。 2014 年 GRC/GRS 的师资队伍必须反映所有参与者的愿望和机会。因此，所有受邀演讲者都是各自领域公认的或新兴的领导者，具有经过验证的沟通和激励能力，并且共同代表整个社区，其中包括非洲研究人员。会议主持人（其中 75% 为女性）将介绍每次演讲的背景并促进讨论。会议场地配备了最先进的视听设施，并提供公共餐饮和休闲活动。但是，它也足够遥远，无法阻止参与者离开该站点。 2014 年 GRC 将延续卓越的传统，人们普遍认为，受邀者尽管是各自领域最繁忙的人之一，但仍立即承诺参加至少 3 天。 2014年的GRC也将有所创新。除了成为免疫学领域第一个提供 GRS 之外，还根据之前会议的评估进行了其他改进。事实上，2014 年 GRC/GRS 将包括经过验证的创新成果分析。 2010 年和 2012 年的会议获得了 NIH 的资助，并获得了提交评估的 95% 参与者中大多数人的最高评价。因此，我们有充分的理由相信，2014 年 GRC 的投资将产生巨大的成效。